Product overview
Type
Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b
Commercial Name
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed
Manufacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India
URL
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
1
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
30 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
a)Carton of 50 vials (50 doses) [Dimensions: 18.5x9.5x5cm] (old, 40mm height); b)(new, 30mm height) [Dimensions: 18.5x9.5x4 cm]
Tertiary Packaging
a)Box of 24 cartons of 50 vials (1200 vials/1200 doses) [Dimensions: 60x48x36 cm]; b)Box of 36 cartons of 50 vial (1800 vials/1800 doses) [Dimensions: 60 x 48 x 48.5 cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.005%
Cold Chain Volume
a)17.575(old); b) 14.06(new) cm3/dose (in secondary packaging)
Attachments
